Week 6 Discussion Fibromyalgia Fibromyalgia (FM) is a chronic musculoskeletal syndrome characterized by diffuse pain, fatigue, increased sensitivity to touch (i.e., tender points), the absence of systemic or localized inflammation, and the presence of fatigue and non-restorative sleep; anxiety and depression also are frequently present (Huether & McCance, 2017). The prominent symptom of fibromyalgia is diffuse, chronic pain (Huether & McCance, 2017). In 2010 the classification of FM was simplified and expanded to include other important non–pain symptoms such as headaches and memory loss, fatigue and irritable bowel syndrome, along with anxiety and depression (Huether & McCance, 2017). The pain often begins in one location, especially the neck and shoulders, but then becomes more generalized. People describe the pain as burning or gnawing (Huether & McCance, 2017) . Fibromyalgia Drug Therapy Treatment should be highly individualized and can include mind-body interventions (such as biofeedback), movement therapies, and relaxation techniques as well as medication (Huether & McCance, 2017). There are three medications that the FDA has approved for the treatment of FM, which consists of pregabalin, duloxetine, and milnacipran (Huether & McCance, 2017). Since no one medication has proven successful in the treatment of FM patients are generally prescribed pain relievers, antidepressants, dual-mechanism medications, and anticonvulsants (Mayo Clinic, 2017). Nociceptive mechanisms usually respond well to traditional approaches to pain management, including common analgesic medications and nonpharmacologic strategies (Arcangelo & Peterson, 2017). Other treatment options include, but are not limited to,
You've reached the end of your free preview.
Want to read all 5 pages?
- Summer '15
- Mayo Clinic, Fibromyalgia, Hashimoto's thyroiditis